Dermatomyositis as a risk factor of carcinogenesis- case report

Слайд 2

Dermatomyositis (DM)
is an idiopathic inflammatory myopathy involving proximal muscle weakness and

Dermatomyositis (DM) is an idiopathic inflammatory myopathy involving proximal muscle weakness and non-suppurative skeletal muscle inflammation
non-suppurative skeletal muscle inflammation

Слайд 3

Epidemiology

Epidemiology

Слайд 4

To zdjęcie, autor: Nieznany autor, licencja: CC BY-SA

To zdjęcie, autor: Nieznany autor,

To zdjęcie, autor: Nieznany autor, licencja: CC BY-SA To zdjęcie, autor: Nieznany
licencja: CC BY-SA

2 to 3 : 1

Female-to-Male incidence ratio

Слайд 5

The most commonly used criteria
1. Symmetric proximal muscle weakness
2. Elevated serum muscle

The most commonly used criteria 1. Symmetric proximal muscle weakness 2. Elevated
enzymes
3. Myopathic changes in electromyography (EMG)
4. Characteristic muscle biopsy abnormalities
5. Typical rash

Слайд 6

INCREASED RISK OF CANCER

Patients with DM must be monitored closely for potential

INCREASED RISK OF CANCER Patients with DM must be monitored closely for
malignancies, as there is an increased risk of cancer, particularly within the first 5 years after symptom onset
The most common cancers seen in patients with DM include
breast colon lung ovarian melanoma non-Hodgkin lymphoma (NHL) nasopharyngeal stomach
The overall cancer rate in patients with DM varies between 9% and 32%.
The highest risk of developing cancer in patients with DM is within the first year of onset of myositis
Dermatomyositis as a paraneoplastic syndrome may precede symptoms and diagnosis of cancer or develop in advanced cancer process

Temporal Relation between the Diagnosis of Dermatomyositis and the Diagnosis of Cancer

https://www.nejm.org/doi/full/10.1056/nejm199202063260602

Слайд 7

Screening

Screening

Слайд 8

Case report

49 year old ,female patient diagnosed with DM in 2016
Early

Case report 49 year old ,female patient diagnosed with DM in 2016
symptoms were:
rash on the face and eyelids,
Gottron sign,
proximal muscle weakness,
difficulties with deglutition and speech.
In the family: endometrial cancer (mother), digestive track cancer( 2 brothers)

The most commonly used criteria
1. Symmetric proximal muscle weakness
2. Elevated serum muscle enzymes
3. Myopathic changes in electromyography (EMG)
4. Characteristic muscle biopsy abnormalities
5. Typical rash

Слайд 9

SKIN SYMPTOMS

SKIN SYMPTOMS

Слайд 10

TREATMENT

no long-term remission
excerebration of the disease
steroids iv in high doses

TREATMENT no long-term remission excerebration of the disease steroids iv in high doses

Слайд 11

Course of a disease

Course of a disease

Слайд 13

Diagnostic laparoscopy

Increased CA-125 value

Diagnostic laparoscopy Increased CA-125 value

Слайд 15

SEROUS FALOPIAN TUBE CANCER

DECISION ABOUT COMPLETE REMOVAL OF REPRODUCTIVE ORGANS

SEROUS FALOPIAN TUBE CANCER DECISION ABOUT COMPLETE REMOVAL OF REPRODUCTIVE ORGANS

Слайд 16

CONCLUSION

Dermatomyositis can be a risk factor of carcinogenesis
It is important to pay

CONCLUSION Dermatomyositis can be a risk factor of carcinogenesis It is important
attention to possibility of cancer development
Patients should be under careful medical supervision